Thomas Goronflot
Impact in
- Parasitology top 10%
- Vector-borne infectious diseases
Papers in
-
- Influenza Virus Research Studies 2
- Oncology 5
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Matthieu Wargny (8 shared papers)Pierre‐Antoine Gourraud (9 shared papers)Bertrand Cariou (6 shared papers)Pierre Gourdy (3 shared papers)Samy Hadjadj (4 shared papers)Matthieu Pichelin (3 shared papers)Thierry Blanchon (3 shared papers)Sarra Smati (3 shared papers)
In The Last Decade
Thomas Goronflot
30 papers receiving 333 citations
Peers
Comparison fields: 5 of 69
- Health Informatics 10
- Parasitology 41
- Infectious Diseases 83
- Health 20
- Nephrology 17
Countries citing papers authored by Thomas Goronflot
This map shows the geographic impact of Thomas Goronflot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Goronflot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Goronflot more than expected).
Fields of papers citing papers by Thomas Goronflot
This network shows the impact of papers produced by Thomas Goronflot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Goronflot. The network helps show where Thomas Goronflot may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Goronflot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 63 | |
| 2 | 2019 | 44 | |
| 3 | 2023 | 40 | |
| 4 | 2020 | 27 | |
| 5 | 2019 | 23 | |
| 6 | 2021 | 16 | |
| 7 | 2019 | 16 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 12 | |
| 10 | Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study. | 2020 | 10 |
| 11 | 2024 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2023 | 3 |
About Thomas Goronflot
Thomas Goronflot is a scholar working on Epidemiology, Oncology, Infectious Diseases, Surgery and Nephrology, having authored 36 papers that have together received 335 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), COVID-19 Clinical Research Studies (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), Influenza Virus Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Acute Kidney Injury Research (2 papers) and Reproductive Biology and Fertility (2 papers). The work is most often cited by research in Health Informatics (10 citations), Parasitology (41 citations), Infectious Diseases (83 citations), Health (20 citations) and Nephrology (17 citations). Thomas Goronflot has collaborated with scholars based in France, Sweden and Spain. Frequent co-authors include Matthieu Wargny, Pierre‐Antoine Gourraud, Bertrand Cariou, Pierre Gourdy, Samy Hadjadj, Matthieu Pichelin, Thierry Blanchon, Sarra Smati, Antoine Rimbert and Cédric Le May. Their work appears in journals such as Diabetes & Metabolism, Eurosurveillance, Lung Cancer, Clinical Lung Cancer and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.